Physiomics gains first large pharma customer for modelling cardiac toxicity risk

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a contract with its first large pharma customer to supply cardiac toxicity risk modelling services.

Read more